• Further Evidence of Feasibility, Validity, and Reliability of Quality of Life-Aged Care Consumers: Evidence From Home-Based Care Settings

    Sep 1, 2024, 00:00

  • Facilitators and Barriers in the Implementation and Adoption of Patient-Reported Outcomes Measurements in Daily Practice

    Sep 1, 2024, 00:00

  • A Feasible Estimation of a “Corrected” EQ-5D Social Tariff

    Sep 1, 2024, 00:00

  • Experience Counts: Unveiling Patients’ Willingness to Pay for Remote Monitoring and Patient Self-Measurement

    Sep 1, 2024, 00:00

  • Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease

    Sep 1, 2024, 00:00

  • Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks [Editor's Choice]

    Sep 1, 2024, 00:00

  • Psychometric Performance of the EQ Health and Wellbeing Short in a United Kingdom Population Sample [Editor's Choice]

    Sep 1, 2024, 00:00

  • A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results?

    Sep 1, 2024, 00:00

  • A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development [Editor's Choice]

    Sep 1, 2024, 00:00

  • Table of Contents

    Sep 1, 2024, 00:00

  • Testing “Pits” Time Trade-Off: Can Data Quality be Improved by Removing Death From Valuation of Health States? [Editor's Choice]

    Sep 1, 2024, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI) [Editor's Choice]

    Sep 1, 2024, 00:00

  • Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer

    Sep 1, 2024, 00:00

  • Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review

    Sep 1, 2024, 00:00

  • A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices

    Sep 1, 2024, 00:00

  • Putting a Dollar Value on Informal Care Time Provided to People Living With Dementia: A Discrete Choice Experiment

    Sep 1, 2024, 00:00

  • Editorial Board

    Aug 27, 2024, 14:04

  • Editorial Board

    Aug 7, 2024, 11:53

  • Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®)

    Aug 1, 2024, 00:00

  • Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation?

    Aug 1, 2024, 00:00

  • Utilization, Expenditure, and Treatment Patterns Associated With Calcitonin Gene-Related Peptide Monoclonal Antibodies Reimbursed Subject to a Managed Access Protocol in Ireland

    Aug 1, 2024, 00:00

  • Navigating Public Policy Responses to a Pandemic: The Balancing Act Between Physical Health, Mental Health, and Household Income

    Aug 1, 2024, 00:00

  • The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States [Editor's Choice]

    Aug 1, 2024, 00:00

  • It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties [Editor's Choice]

    Aug 1, 2024, 00:00

  • Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review [Editor's Choice]

    Aug 1, 2024, 00:00

  • Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States

    Aug 1, 2024, 00:00

  • Treatment Effect Waning Assumptions: A Review of National Institute of Health and Care Excellence Technology Appraisals [Editor's Choice]

    Aug 1, 2024, 00:00

  • The Long COVID Symptoms and Severity Score: Development, Validation, and Application

    Aug 1, 2024, 00:00

  • EQ-5D-5L Population Norms for China Derived From a National Health Survey

    Aug 1, 2024, 00:00

  • Table of Contents

    Aug 1, 2024, 00:00

  • Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma

    Aug 1, 2024, 00:00

  • How Do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study

    Aug 1, 2024, 00:00

  • Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019

    Aug 1, 2024, 00:00

  • A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity

    Aug 1, 2024, 00:00

  • Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L [Editor's Choice]

    Aug 1, 2024, 00:00

  • Validating Health Economic Models With the Probabilistic Analysis Check dashBOARD

    Aug 1, 2024, 00:00

  • Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial

    Jul 1, 2024, 00:00

  • Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample [Editor's Choice]

    Jul 1, 2024, 00:00

  • Understanding the Complex Interactions Between Interventions, Well-Being, and Resource Allocation

    Jul 1, 2024, 00:00

  • Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions

    Jul 1, 2024, 00:00

  • From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year [Editor's Choice]

    Jul 1, 2024, 00:00

  • Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation

    Jul 1, 2024, 00:00

  • Values Beyond “Health” in Budget-Constrained Healthcare Systems [Editor's Choice]

    Jul 1, 2024, 00:00

  • The Ceiling Effects of EQ-5D-3L and 5L in General Population Health Surveys: A Systematic Review and Meta-Analysis

    Jul 1, 2024, 00:00

  • The Measurement Properties of the EQ-HWB and the EQ-HWB-S in Italian Population: A Comparative Study With EQ-5D-5L

    Jul 1, 2024, 00:00

  • A Head-to-Head Comparison of EQ-HWB and EQ-5D-5L in Patients, Carers, and General Public in China

    Jul 1, 2024, 00:00

  • Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors

    Jul 1, 2024, 00:00

  • Construct Validity, Reliability, and Responsiveness of the 10-Item Well-Being Instrument for Use in Economic Evaluation Studies [Editor's Choice]

    Jul 1, 2024, 00:00

  • Table of Contents

    Jul 1, 2024, 00:00

  • Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making

    Jul 1, 2024, 00:00

  • Editorial Board

    Jul 1, 2024, 00:00

  • Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement

    Jul 1, 2024, 00:00

  • Subjective Well-Being Population Norms and Inequalities in Hungary: A Large Cross-Sectional, Internet-Based Survey

    Jul 1, 2024, 00:00

  • Comparison of the EQ-HWB and EQ-HWB-S With Other Preference-Based Measures Among United States Informal Caregivers [Editor's Choice]

    Jul 1, 2024, 00:00

  • Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector [Editor's Choice]

    Jul 1, 2024, 00:00

  • Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study

    Jul 1, 2024, 00:00

  • Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

    Jul 1, 2024, 00:00

  • Editorial Board

    Jun 12, 2024, 08:53

  • HTA6 Use of Medical Device Assessment Criteria in CONITEC Evaluations

    Jun 1, 2024, 00:00

  • PCR186 Understanding the Participant Experience of Qualitative Interview Studies To Inform Future Study Design: Analysis of Feedback Forms

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • RWD166 Evaluation of the One-Day Surgical Performance of the Hungarian Universities in the Obstetrics and Gynecology Medical Field

    Jun 1, 2024, 00:00

  • MT15 Postoperative Clinical and Economic Outcomes of Patients With Reverse or Anatomic Total Shoulder Arthroplasty at One Year: A Retrospective, United States Hospital Billing Database Analysis

    Jun 1, 2024, 00:00

  • EE82 Health Care Resource Use Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • PCR165 Health-Related Quality of Life of Type 1 Diabetes and Severe Hypoglycemia in Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • EE19 Cost-Effectiveness Analysis of Infliximab, Adalimumab, and Certolizumab for Crohn's Disease: A Markov Model Study

    Jun 1, 2024, 00:00

  • CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Specific Adverse Events in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • EE49 Public Health Impact and Cost-Effectiveness of a New Dengue Vaccine (TAK-003) in a Large Catch-up Cohort in Puerto Rico

    Jun 1, 2024, 00:00

  • HTA34 Cost-Effectiveness Analysis of Icosapent Ethyl (IPE) for the Reduction of the Severe Hypertriglyceridemia (HTG) in China

    Jun 1, 2024, 00:00

  • HTA18 Heading into the Unknown: How Will JCA Implementation Affect Global Launch Strategies?

    Jun 1, 2024, 00:00

  • HSD1 Assessing Community Pharmacist Expectation, Satisfaction, and Intentions in the Wasfaty E-Servi Using the Expectation Conformation Theory

    Jun 1, 2024, 00:00

  • PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study

    Jun 1, 2024, 00:00

  • EPH132 Adverse Drug Reaction-Related Hospital Admission in Older Australians With Dementia

    Jun 1, 2024, 00:00

  • PCR66 Improving Quality of Life in Endometriosis Patients: A Study on Lifestyle and Pain Scores

    Jun 1, 2024, 00:00

  • EE485 Cost-Effectiveness of Active Surveillance for Incidentally Detected Early-Staged Papillary Thyroid Cancer: A Microsimulation Study

    Jun 1, 2024, 00:00

  • RWD190 The Impact of a Colorectal Cancer Diagnosis on Health Resource Utilization Patterns Among Patients With Hypertension Using Real-World Data

    Jun 1, 2024, 00:00

  • CO91 Systemic Therapy Eligibility Criteria of the International Psoriasis Council (IPC) May Reduce Undertreatment of PsO Patients with Low Body Surface Area Involvement Associated with High Disease Burden

    Jun 1, 2024, 00:00

  • EE8 Targeted Literature Review for Estimating Median Age of Causal Human Papilloma Virus Infection to Oropharyngeal Cancer

    Jun 1, 2024, 00:00

  • EPH108 Clopidogrel Resistance in Patients With Recurrent Ischaemic Stroke on Dual Antiplatelet Therapy and Its Economic Impact in a Lower-Middle Income Country: A Single Centered Study in Southern India

    Jun 1, 2024, 00:00

  • HPR18 What Is the Impact of Including Outcomes-Based Agreements on the Cost-Effectiveness of Cell and Gene Therapies? A Case Example of Zynteglo for Transfusion-Dependent Beta Thalassemia

    Jun 1, 2024, 00:00

  • CO26 Targeted Literature Review Exploring Burden of Disease in Junctional and Dystrophic Epidermolysis Bullosa

    Jun 1, 2024, 00:00

  • PCR209 Joint Modeling of Progression-Free Survival (PFS) and Patient-Reported Symptoms Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients

    Jun 1, 2024, 00:00

  • EE293 A Framework to Assess Uncertainties of Polygenic Risk Scores in Disease Screening and Prevention in Cost-Effectiveness Analyses

    Jun 1, 2024, 00:00

  • EE358 Systematic Literature Review of Cost-Effectiveness Analyses of Adult 15- and 20-Valent Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • RWD192 Real-World Use of Tirzepatide Among People Without Evidence of Type 2 Diabetes: Results From Merative Marketscan Commercial Database

    Jun 1, 2024, 00:00

  • SA68 Assessment of Real-World Data Sources and a Hybrid Approach in Real-World Evidence Generation Using Unharmonized Data Sources

    Jun 1, 2024, 00:00

  • EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective

    Jun 1, 2024, 00:00

  • EE277 Budget Impact Analysis of Anaprazole for the Treatment of Duodenal Ulcer in China

    Jun 1, 2024, 00:00

  • EE76 Anterior-Based Muscle-Sparing Approach (ABLE) Is Cost-Effective When Compared with Posterolateral and Direct Anterior Approaches for Total Hip Arthroplasties

    Jun 1, 2024, 00:00

  • EE274 Cost-Effectiveness Analysis of Large-Scale Screening for Celiac Disease in the Pediatric Population

    Jun 1, 2024, 00:00

  • SA78 An Overview of Methods Employed in Economic Models of Cancer Screening Tests: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • PCR207 Health-Related Quality of Life and Its Associate Factors Among Residents in Tianjin, China: Findings from 2023 National Health Service Survey

    Jun 1, 2024, 00:00

  • PCR258 Work Productivity and Activity Impairment Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare

    Jun 1, 2024, 00:00

  • CO151 A Preliminary Analysis of Oral Edaravone-Treated Patients With Amyotrophic Lateral Sclerosis Enrolled in a US-Based Administrative Claims Database

    Jun 1, 2024, 00:00

  • RWD123 Clinical and Hospital Related Outcomes of Journey II Knee System Compared to Other Knee Systems in the Management of Total Knee Arthroplasty (TKA) Patients

    Jun 1, 2024, 00:00

  • HPR88 Variation in State Medicaid Use of Brand-over-Generic Preferred Drug Lists

    Jun 1, 2024, 00:00

  • CO108 The Effect of Approved Anti-Obesity Medications in Patients With Alcohol and Substance Abuse Disorder

    Jun 1, 2024, 00:00

  • PT14 The Effectiveness of Bisphosphonates on Recurrent Osteoporotic Fractures Post-Denosumab Discontinuation Using Causal Machine Learning

    Jun 1, 2024, 00:00

  • EPH181 Real World Retrospective Analysis of Short-Term Disability Claims for the Genitourinary System in the United States

    Jun 1, 2024, 00:00

  • EE182 Mepolizumab Impact on Healthcare Resource Utilization and Work Productivity in Patients with Severe Asthma: REALITI-A 2-Year Analysis

    Jun 1, 2024, 00:00

  • MSR57 Transforming Systematic Literature Reviews: Unleashing the Potential of GPT-4: A Cutting-Edge Large Language Model, to Elevate Research Synthesis

    Jun 1, 2024, 00:00

  • MT48 Assessment of a Patient-Centric Web Application Tool for Potential Adverse Events of Oral Corticosteroids

    Jun 1, 2024, 00:00

  • P44 Cost-Effectiveness of Eliglustat Tartrate for the Treatment of Type 1 Gaucher Disease in China Using a Semi-Markov Model

    Jun 1, 2024, 00:00

  • EE128 Customer Service Analytics Improve Health Outcomes at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • PCR192 Using Linked Claims and EHR Real-World Data to Determine Medication Adherence Among Common Therapeutic Areas of Chronic Disease

    Jun 1, 2024, 00:00

  • CO161 Adherence and Persistence To Oral Targeted Therapies for Non-Small-Cell Lung Cancer and Association With Survival Outcomes

    Jun 1, 2024, 00:00

  • EE405 Residual Burden in Adalimumab-Treated Patients with Hidradenitis Suppurativa

    Jun 1, 2024, 00:00

  • HTA11 Manufacturer Engagement and Revision Outcomes in the “Phase Contradictoire” of the HTA Process in Fran A Descriptive Analysis

    Jun 1, 2024, 00:00

  • CO141 Situation Report: Health Status of Hungarian Ambulance Workers in the COVID Era

    Jun 1, 2024, 00:00

  • MSR34 Diversity in Clinical Trials: Life Science Initiatives and Challenges in Light of the FDA’s Latest Guidance

    Jun 1, 2024, 00:00

  • PCR132 Disparities in Patient Reported Outcomes Completion Rates and Baseline Function in Newly Presenting Spine Patients

    Jun 1, 2024, 00:00

  • HPR111 Disease Burden and Medical Insurance Expenditure of National Price-Negotiated Drugs for Multiple Sclerosis Under Dual-Channel Model in China: A Budget Impact Model

    Jun 1, 2024, 00:00

  • HPR105 Breadth of Patient and Stakeholder Input in CMS's Drug Price Negotiation Program: A Content Analysis of the 2023 Patient-Focused Listening Sessions

    Jun 1, 2024, 00:00

  • EPH163 Off-Label Use of Semaglutide in the United States: Increasing Prevalence, Variability in Prescribing Provider Specialty, and Patient Characteristics

    Jun 1, 2024, 00:00

  • EE195 The Cost of Missing Physiotherapy Appointments

    Jun 1, 2024, 00:00

  • EPH127 Association of Marijuana Use With Poor Mental Health Among Non-Institutionalized Adults in the US

    Jun 1, 2024, 00:00

  • CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2024, 00:00

  • CO193 Real-World Retrospective Analysis Comparing a Bilayered Living Cellular Construct and a Fetal Bovine Collagen Dressing for Use in Venous Leg Ulcers

    Jun 1, 2024, 00:00

  • OP13 A Descriptive Analysis of Key Findings from the 2023-24 ISPOR Student Interest Survey

    Jun 1, 2024, 00:00

  • MT42 Evaluation of a Novel Single-Use Ureteroscope: User Satisfaction Comparison Survey

    Jun 1, 2024, 00:00

  • MSR53 Estimands in EQ-5D-5L: How to Deal with the “Worse Than Death” and the Intercurrent Events of “Death”

    Jun 1, 2024, 00:00

  • HPR113 Equity in Antenatal Care Quality: An Analysis of 11.382 Cases from 23 Municipalities in Colombia

    Jun 1, 2024, 00:00

  • EE329 Budget Impact of Low-Dose Computed Tomography Screening for Lung Cancer in Argentina

    Jun 1, 2024, 00:00

  • CO200 Gender Differences in Clinician-Recorded Side Effects Among People With First Episode Psychosis: Real-World Evidence From Electronic Health Record Data

    Jun 1, 2024, 00:00

  • HTA63 The Role and Implementation of Patient and Public Involvement in Health Technology Assessment: A Systematic Search and Implications for Japan

    Jun 1, 2024, 00:00

  • PCR238 Estimating Health State Utilities (HSUS) for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in the United States

    Jun 1, 2024, 00:00

  • SA60 The Use of Natural Language Processing in Literature Reviews

    Jun 1, 2024, 00:00

  • HPR80 Moving Towards Inclusion: A Review of Access to Oncologic Therapies in the Light of Global Efforts to Advance Gender Equality

    Jun 1, 2024, 00:00

  • EE366 Healthcare Costs Comparison of Dupilumab Vs. Omalizumab, Benralizumab and Mepolizumab in Patients with Moderate-to-Severe Asthma: A US Payer Perspective

    Jun 1, 2024, 00:00

  • HTA23 Caregiver Health-Related Quality of Life in National Institute for Health and Care (NICE) Appraisals: From Inception to 2023

    Jun 1, 2024, 00:00

  • PCR197 Health-related Quality of Life (HRQoL) Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic Review

    Jun 1, 2024, 00:00

  • EPH153 Screening Interval for Colonoscopic Screening for Colorectal Cancer: A Systematic Review of Interval Cancer Rates of Colonoscopic Screening for Colorectal Cancer

    Jun 1, 2024, 00:00

  • CO179 The Association Between Social Determinants of Health, COVID-19, and Incidence of De Novo Depression Following Traumatic Brain Injury

    Jun 1, 2024, 00:00

  • CO99 Validation of Overall Survival (OS) Extrapolations Using 5-Year Follow-up Data From the Keynote-177 MSI-H/dMMR Metastatic Colorectal Cancer (mCRC) Study

    Jun 1, 2024, 00:00

  • RWD33 An Overview of Real-World Studies on Central Nervous System Diseases in China: A Decade of Data and Insights

    Jun 1, 2024, 00:00

  • EE427 The Reduction in Medical and Care Costs for Diseases Associated with Being Bedridden in Rural Residents in Japan

    Jun 1, 2024, 00:00

  • EE440 Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination in Adults Aged 50-59 Years With Cardiopulmonary Diseases in the United States

    Jun 1, 2024, 00:00

  • SA22 Does the Use of Investigator-Choice Comparator Arms in Oncology Clinical Trials Influence Payer Assessments Outcomes?

    Jun 1, 2024, 00:00

  • EE170 Social and Clinical Factors Influencing ED Utilization Behavior Amongst Blue Cross Blue Shield of Louisiana Members: A Cluster Analysis

    Jun 1, 2024, 00:00

  • EE488 Cost-Effectiveness Analysis of Faricimab and Others Treatment Schemes for Diabetic Macular Edema and Age-Related Macular Degeneration

    Jun 1, 2024, 00:00

  • MSR63 Improving Efficiency in Analysis of Real-World Data with an Automated Machine Learning Tool

    Jun 1, 2024, 00:00

  • RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data

    Jun 1, 2024, 00:00

  • HSD64 Data Visualization of Patterns of Adjuvant Endocrine Therapy Among Older Women With Hormone-Positive Early-Stage Breast Cancer

    Jun 1, 2024, 00:00

  • EPH89 Telehealth Utilization Among Children with Autism Spectrum Disorder in Employer-Sponsored Plans, 2019–2022

    Jun 1, 2024, 00:00

  • EE284 Cost-Effectiveness Analysis of Larotrectinib and Entrectinib for Adult Patients with NTRK Gene Fusion-Positive Breast Cancer

    Jun 1, 2024, 00:00

  • P56 Extraction of Inflammatory Bowel Disease Severity Scores from Unstructured Clinical Notes Using a Retriever-Reader Architecture

    Jun 1, 2024, 00:00

  • HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?

    Jun 1, 2024, 00:00

  • EPH7 Examination of Weight-Related Coding Practices in Administrative Claims: Implications for Future Analyses

    Jun 1, 2024, 00:00

  • EE462 Healthcare Utilization in Non-Alcoholic Steatohepatitis (NASH) Patients with Elevated Nafld Activity Score (NAS): Impact of Fibrosis Levels

    Jun 1, 2024, 00:00

  • EPH111 Diabetes' Prevalence by Gender, Age, and Race in the United States (Trends Between 2005 and 2019)

    Jun 1, 2024, 00:00

  • Reviewer Acknowledgment

    Jun 1, 2024, 00:00

  • HPR96 Racial Disparity and Awareness of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis

    Jun 1, 2024, 00:00

  • EPH10 Serotype Distribution Among Streptococcus Pneumoniae Isolates in Puerto Rico (PNEUMOSER STUDY)

    Jun 1, 2024, 00:00

  • PCR233 Adherence and Persistence of Oral Anticoagulants for Treatment of Atrial Fibrillation across Stroke and Bleeding Risk Strata

    Jun 1, 2024, 00:00

  • MSR97 Indirect Estimation of Post-Distant Recurrence Survival (PDRS) for Resected Stage II/III Melanoma: A Network-Meta Analysis (NMA) Approach

    Jun 1, 2024, 00:00

  • Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability

    Jun 1, 2024, 00:00

  • EPH158 Using Data to Develop Precision Medicine Approaches to Public Health Initiatives

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • EPH206 Incidence and Risk Factors for Empiric Treatment Failure Among Females With Uncomplicated Urinary Tract Infections in an Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • HPR117 Emergency Room Utilization Among Multiple Sclerosis Patients Treated with Disease-Modifying Therapy in a Real-World Hybrid Claims Database

    Jun 1, 2024, 00:00

  • EE457 Economic Burden Impact of Thyroid Eye Disease in the United Arab Emirates

    Jun 1, 2024, 00:00

  • RWD145 Healthcare Resource Utilization (HCRU) and Costs Among Previously-Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Retrospective Analysis of SEER-Medicare Linked Claims

    Jun 1, 2024, 00:00

  • EPH87 Invasive Meningococcal Disease Risk Factors in Individuals With Commercial and Medicare Insurance in the United States

    Jun 1, 2024, 00:00

  • EE151 Clinical and Economic Benefits of Adjuvanted and High-Dose Influenza Vaccines in the Elderly in Argentina

    Jun 1, 2024, 00:00

  • EE16 Economic Analysis of the Impact of Delandistrogene Moxeparvovec Gene Therapy on Work Opportunity in Caregivers of Individuals with Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • RWD100 Assessing the Representativeness of Real-World Claims Databases

    Jun 1, 2024, 00:00

  • HPR104 How Well Can Insurers Police Off-Label Use? Evidence from GLP-1s in Medicare Part D

    Jun 1, 2024, 00:00

  • HSD16 Understanding Causes and Consequences in the Operating Room Associated with Distractions, Interruptions, and Disruptions: A Focused Literature Review

    Jun 1, 2024, 00:00

  • MSR3 Cough, Dyspnea, Chest Pain or a Composite? Analysis of Key Symptoms in Metastatic Non-Small Cell Lung Cancer (mNSCLC) Clinical Trials

    Jun 1, 2024, 00:00

  • HSD41 Disparities by Gender, Race and Geography Exist in Whether Patients Receive a Confirmatory Celiac Disease Endoscopy and Biopsy After Screening Positive

    Jun 1, 2024, 00:00

  • HTA59 Reception of RWE: A Deep Dive Into Recent Trends in CADTH Reimbursement Reviews

    Jun 1, 2024, 00:00

  • EE132 Economic Outcomes and Real-World Adherence of Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises Treated With L-Glutamine, Voxelotor, and Crizanlizumab in the United States

    Jun 1, 2024, 00:00

  • HPR30 Variation in per Beneficiary Prescription Utilization and Spending By Race/Ethnicity in Medicare and Medicaid Insurance Claims

    Jun 1, 2024, 00:00

  • MSR45 Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients With Atrial Fibrillation and Cancer

    Jun 1, 2024, 00:00

  • HSD123 Prescription Opioid Dispensings in Medicare Part D in 2020 by US Region and Prescriber Type

    Jun 1, 2024, 00:00

  • EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists

    Jun 1, 2024, 00:00

  • RWD105 The Clinical and Economic Burden of Woman with Endometriosis (EM)

    Jun 1, 2024, 00:00

  • MSR105 Proportional Randomization Method to Identify Index Line of Therapy in Externally Controlled Trials

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • EE288 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in Germany

    Jun 1, 2024, 00:00

  • MT4 The Trend, Outcomes, and Resources Utilization of Surgical Staplers Used in Patients Treated with Robotic Gastric Sleeve Procedures

    Jun 1, 2024, 00:00

  • EE258 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for High-Risk Patients in Chile

    Jun 1, 2024, 00:00

  • SA27 Reduction in Corticosteroid Use Among Patients With Focal Segmental Glomerulosclerosis, Membranous Nephropathy, or IgA Nephropathy after Acthar® Gel in a Large Administrative Claims Database

    Jun 1, 2024, 00:00

  • EPH73 Clinical Characteristics of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria

    Jun 1, 2024, 00:00

  • EPH120 Incidence, Prevalence and Clinical Characteristic of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • RWD160 An Episode-Based Analysis in a Medicare Advantage Population to Identify the Cost Impact of Virtual-First Care for Common Acute Conditions

    Jun 1, 2024, 00:00

  • EE496 Cost of Anti-CD38 Monoclonal Antibodies in Combination With Carfilzomib and Dexamethasone for Relapsed Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • RWD97 Real-World Disease Burden of Fibrodysplasia Ossificans Progressiva in China

    Jun 1, 2024, 00:00

  • EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis

    Jun 1, 2024, 00:00

  • EE160 Evidence to Inform Forecasts of Biopharmaceutical Policy Impact

    Jun 1, 2024, 00:00

  • EE86 Cost-Effectiveness of Tivozanib in Advanced Renal Cell Carcinoma in the US

    Jun 1, 2024, 00:00

  • SA2 A Unique Approach for Identifying Thoracic Endovascular Aortic Repair Stent Graft Landing Zones 0/1/2 Using Revascularization Procedure Codes from a Commercial Claims Database

    Jun 1, 2024, 00:00

  • PCR225 The Caregiver Perspective on Dry Age-Related Macular Degeneration: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • HSD120 Effectiveness of Pharmacist-Led Interventions on Medication Use and Related Health Outcomes in Patients With Alzheimer's Disease and Related Dementias: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR38 Health-Related Quality of Life Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • EE148 The Institutional Level Impact of Additional Apheresis Days for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation on Costs and Healthcare Resource Utilization

    Jun 1, 2024, 00:00

  • Modeling for HTA

    Jun 1, 2024, 00:00

  • RWD69 Utilization of Current Procedural Terminology Codes in Pharmacists' Services Using Medicare Data Claims

    Jun 1, 2024, 00:00

  • EE78 Economic and Comorbidity Burden of Prurigo Nodularis and Drivers of Higher Healthcare Costs in the US: A Retrospective Analysis of Claims Data of Patients Diagnosed Between 2017 and 2022

    Jun 1, 2024, 00:00

  • HPR109 Evaluation of Evidence Informing Medicare’s Coverage With Evidence Development Decision Updates

    Jun 1, 2024, 00:00

  • EPH63 Epidemiological Disease Burden of Female Infertility of Other Origin Based on Routinely Collected Health Insurance Claims Data between 2010-2019

    Jun 1, 2024, 00:00

  • HPR21 Healthcare Expenditure and Its Association with Under Five Mortality: A Cross-Country Analysis in the Eastern Mediterranean Region

    Jun 1, 2024, 00:00

  • EE368 Claims-Based Comparison of Characteristics and Healthcare Costs Between Mothers With and Without Postpartum Depression

    Jun 1, 2024, 00:00

  • EE252 Economic Impact of Relapses in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Literature Review

    Jun 1, 2024, 00:00

  • RWD154 Evaluation of Mortality Data Sources for Use in Real-Word Data Analyses

    Jun 1, 2024, 00:00

  • EE79 Real-World Clinical and Economic Burden of Primary Biliary Cholangitis in the United States

    Jun 1, 2024, 00:00

  • Understanding the National Institute for Health and Care Excellence Severity Premium: Exploring Its Implementation and the Implications for Decision Making and Patient Access [Editor's Choice]

    Jun 1, 2024, 00:00

  • EE250 Work Productivity Loss Among Adults Aged 18–64 Years With Osteoarthritis in the United States: 2016-2020

    Jun 1, 2024, 00:00

  • EE3 Cost Effectiveness Model on Four Preventive Treatment for Clostridioides Difficile Infection Recurrence From a US Payer Perspective

    Jun 1, 2024, 00:00

  • HSD113 Treatment Patterns, Comorbidities, Healthcare Resource Utilization and Related Costs of Dermatomyositis and Polymyositis in the United States: A Cohort Study in the Merative™ MarketScan® Database

    Jun 1, 2024, 00:00

  • P59 A Microsimulation Model for High-Risk Stage II and Stage III Colon Cancer Survivors Following the Current Guidelines

    Jun 1, 2024, 00:00

  • MT47 Navigating the Roadblocks: Identifying the Complexities and Challenges of Artificial Pancreas in Management of Type 1 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • HSD57 Current Status of Off-Label IV Ketamine Utilization for Mood Disorders: A Nationwide Survey of Ketamine Clinics, Treatment Processes, and Provider Perceptions of Outcomes

    Jun 1, 2024, 00:00

  • PCR228 Healthcare Provider Preferences for Attributes of Influenza Vaccines in the United States: Results From a Discrete-Choice Experiment Study

    Jun 1, 2024, 00:00

  • EE181 Impact of Type 1 Diabetes on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitoring Users in the United States: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • EE510 Navigating Economics of Telehealth in Oncology

    Jun 1, 2024, 00:00

  • MSR36 Current Applications of Machine Learning for Causal Inference in Healthcare Research Using Observational Data

    Jun 1, 2024, 00:00

  • PCR13 Bridging the Gap: User Engagement in Developing and Implementing Digital Medication Adherence Technologies

    Jun 1, 2024, 00:00

  • RWD87 Real-World Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization in Patients in the US With Metastatic Non-Small Cell Lung Cancer Receiving Systemic Anticancer Therapy

    Jun 1, 2024, 00:00

  • EE33 Cost-Effectiveness of Aducanumab, Lecanemab, and Donanemab for Early Alzheimer Disease in the US

    Jun 1, 2024, 00:00

  • HTA75 Utilization of Artificial Intelligence By Health Technology Assessment Agencies to Improve Efficiency of Health Technology Appraisals

    Jun 1, 2024, 00:00

  • EE469 Societal Costs of Alzheimer's Disease: Informal Caregiver Burden and Patient Productivity Loss

    Jun 1, 2024, 00:00

  • EE437 Evaluating Various Predictors Suspected of Influencing Biosimilar Market Share in the U.S.

    Jun 1, 2024, 00:00

  • CO104 Clinical Outcomes of Second-Line and Beyond (2L+) Treatments (TXS) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • PCR52 Early Real-World Experience With Abrilada Within the Canadian Patient Population

    Jun 1, 2024, 00:00

  • HPR125 Novel Drug Approvals By the U.S. Food and Drug Administration in Rare Diseases: Findings from 2020–2023

    Jun 1, 2024, 00:00

  • EE154 The Economic Burden of HER2+ Breast Cancer and the Epidemiological Economic Impact of Targeted Therapies in the Dominican Republic

    Jun 1, 2024, 00:00

  • EPH183 The Association Between the Minority Health Social Vulnerability Index and Pneumococcal Disease Incidence Among Medicare Beneficiaries (2016-2019)

    Jun 1, 2024, 00:00

  • PCR221 Sunbathing Habits, Knowledge A Level, and Sun Protection Related to Skin Cancers Among Adults

    Jun 1, 2024, 00:00

  • PCR64 Examining the Disability Paradox and Health State Utility Valuation in Achondroplasia

    Jun 1, 2024, 00:00

  • HPR54 The European Health Data Space (EHDS): Probable Impact, Possible Challenges and Proposed Solutions to Using Electronic Health Records (EHRS) for Research and Policy Shaping in the Region

    Jun 1, 2024, 00:00

  • PT44 Prevalence of Comorbidities and Hospitalization in the 65 and over SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) Patient Population: A Comparative Analysis of the FORWARD Lupus Registry and Medicare Data in the US (2017-2021)

    Jun 1, 2024, 00:00

  • HSD81 Impact of Specialty Pharmacy: A Study in Inflammatory Conditions

    Jun 1, 2024, 00:00

  • PCR48 Health-Related Quality of Life for Disease-Modifying Therapies Among Patients With Spinal Muscular Atrophy in Taiwan

    Jun 1, 2024, 00:00

  • RWD165 Burden of Illness of Intrauterine Adhesions Following Intrauterine Procedures: A Retrospective Analysis of Real-World Data

    Jun 1, 2024, 00:00

  • PCR62 Household Costs for Home, Vehicle, and Medical Equipment Expenditures to Accommodate Functional Impairments for Individuals with Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • CO66 Optimizing GPT-4 Prompts for Population Eligibility Screening in COA Landscape Reviews of Qualitative Studies

    Jun 1, 2024, 00:00

  • PCR81 Association between Video Gaming Habits and Psychological Distress Among Adolescents

    Jun 1, 2024, 00:00

  • PCR99 Mixed Methods Research to Understand Disease Burden and Unmet Need in HDFN and FNAIT

    Jun 1, 2024, 00:00

  • RWD54 Comparative Analysis of Different Methods of Disease Progression Data Capture in Patients With Metastatic Castration-Resistant Prostate Cancer

    Jun 1, 2024, 00:00

  • EPH168 Incidence of Pre-Dialysis Depression and Its Impact on Chronic Kidney Disease (CKD) Progression

    Jun 1, 2024, 00:00

  • CO137 Are Standard Indirect Treatment Comparison Methods Suitable to Compare First-Line Vs Maintenance Therapies? An Assessment of Enfortumab Vedotin + Pembrolizumab Vs Avelumab in Locally Advanced/Metastatic Urothelial Carcinoma

    Jun 1, 2024, 00:00

  • RWD6 Effect of Selumetinib Treatment on Pain Medication Utilization in Pediatric Patients: A US Claims Database Analysis

    Jun 1, 2024, 00:00

  • HPR100 Health Technologies Value Assessment Through the Lens of Health Equity; How Far From Being Incorporated Routinely? An Environmental Scan of Health Equity Frameworks and Policy Gaps

    Jun 1, 2024, 00:00

  • EE475 The Benefit-Cost Analysis Adjustment Through the Generalized Risk-Adjustment Cost-Effectiveness (GRACE) Framework: An Application on Acute Ischemic Stroke Patients

    Jun 1, 2024, 00:00

  • EE463 A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab (NIVO+IPI) Vs Pembrolizumab Plus Axitinib (PEM+AXI) for the First-Line Treatment of Intermediate or Poor (I/P)-Risk Advanced Renal Cell Carcinoma Patients in Peru

    Jun 1, 2024, 00:00

  • MSR59 Advancing Systematic Literature Reviews: The Integration of AI-Powered NLP Models in Data Collection Processes

    Jun 1, 2024, 00:00

  • EPH226 Associations between Antimicrobial Susceptibility of Streptococcus Pneumoniae and Disease Severity Outcomes in Older Adults with Invasive Pneumococcal Disease in Sao Paulo, Brazil

    Jun 1, 2024, 00:00

  • EE66 Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan

    Jun 1, 2024, 00:00

  • HPR89 Trends in Hospital Charging Practices from 2019-2022 Among Hospitals with and without Chimeric Antigen Receptor (CAR) T-Cell Therapy Utilization

    Jun 1, 2024, 00:00

  • P3 Longitudinal Analyses of Healthcare Resource Utilization and Costs Among Patients with Obstructive Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • RWD158 Assessing RSV Vaccination Trends in the Context of Seasonal RSV Diagnoses Using Near Real-Time Administrative Claims

    Jun 1, 2024, 00:00

  • CO169 Ensifentrine, an Investigational, Inhaled PDE3/4 Inhibitor, Decreased COPD-Related Healthcare Resource Utilization over 24 Weeks

    Jun 1, 2024, 00:00

  • PCR124 Burden of Fracture and Fracture Management Among Individuals with Osteogenesis Imperfecta: Results from a Survey of Adults and Caregivers

    Jun 1, 2024, 00:00

  • HSD91 ‘It Is Not in Stock’: Identifying Determinants of Patient Deception in Community Pharmacies

    Jun 1, 2024, 00:00

  • PCR196 Psychometric Validation of the PROMIS Fatigue-Short Form 7A in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

    Jun 1, 2024, 00:00

  • AI and Machine Learning in HEOR

    Jun 1, 2024, 00:00

  • HTA17 Cost-Effectiveness Analysis of Capivasertib Plus Fulvestrant in Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2-) Negative Advanced Breast Cancer: A US Payer Perspective

    Jun 1, 2024, 00:00

  • RWD44 Key Components of a Strong Real World Data Quality and Relevance Package for Regulatory or Health Technology Assessment Submission

    Jun 1, 2024, 00:00

  • SA28 Using Linked Claims-EHR Data: The Added Value When Assessing Comorbidity Burden Among Patients With Asthma

    Jun 1, 2024, 00:00

  • PCR141 Smoldering Multiple Myeloma: A Multi-Country Mixed-Methods Study on Disease Perceptions and Patient Treatment Preferences

    Jun 1, 2024, 00:00

  • EPH200 Epidemiological Disease Burden of Female Infertility Associated with Male Factors Based on Routinely Collected Health Data between 2010-2019

    Jun 1, 2024, 00:00

  • EPH130 Mortality Related with Respiratory Syncytial Virus (RSV) Specific and Unspecified Acute Bronchiolitis in Under 2 Years in Colombia, 2012-2021

    Jun 1, 2024, 00:00

  • MSR9 Can Artificial Intelligence Tools Enhance Data Abstraction During Systematic Literature Reviews?

    Jun 1, 2024, 00:00

  • HPR132 Employer Perspectives on Alternative Funding Programs

    Jun 1, 2024, 00:00

  • CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade

    Jun 1, 2024, 00:00

  • EE44 Outcomes and Cost-Effectiveness of Hospital Outpatient Versus Ambulatory Surgery Center Lumbar Decompression Surgery

    Jun 1, 2024, 00:00

  • EPH107 Characteristics of the COVID-19 Epidemic in Three Hungarian Disctricts

    Jun 1, 2024, 00:00

  • CO139 Comparative Effectiveness of Rapid Vs. Non-Rapid Start of Anti-Retroviral Therapy in Patients With Human Immunodeficiency Virus Infection on Clinical Outcomes: A Systematic Literature Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • EE482 Building Better Models: A Simulation Case Study Demonstrating the Crucial Role of Ergodicity in Building Robust Markov Chains

    Jun 1, 2024, 00:00

  • SA31 Fall-Related Risks with Pharmacological Interventions in Mild-to-Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE501 Estimating the Impact of Delayed Treatment for Major Depressive Disorder Using a Continuous-Time Patient-Level Simulation Model

    Jun 1, 2024, 00:00

  • Addressing Confounding in Real-World Evidence Studies

    Jun 1, 2024, 00:00

  • EPH46 Prognostic and Risk Factors of Psoriatic Arthritis Among Adult Psoriasis Patients in the United States: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE309 Cost-Effectiveness Analysis of Velmanase Alfa in Patients with Alpha Mannosidosis from a UK Health Service Perspective

    Jun 1, 2024, 00:00

  • HSD51 Evaluation of the Healthcare System Burden Associated With Intravenous Treatment for Paroxysmal Nocturnal Hemoglobinuria

    Jun 1, 2024, 00:00

  • EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan

    Jun 1, 2024, 00:00

  • P54 Evaluating ChatGPT's Efficacy and Efficiency in the Risk of Bias Assessment in Health Economic Evaluations: A Comparative Analysis Using the Drummond Checklist

    Jun 1, 2024, 00:00

  • AI and Machine Learning to Address Equity and Fairness in Healthcare

    Jun 1, 2024, 00:00

  • RWD146 Characterization of Chronic Kidney Disease Patients By eGFR Status Using Health Insurance Claims Linked to Lab Testing Data

    Jun 1, 2024, 00:00

  • HPR6 Inflation Reduction Act: How Will the First 10 Drugs Selected for Medicare Price Negotiations Impact US Commercial Payers?

    Jun 1, 2024, 00:00

  • MSR55 Predictive Horizons: Unveiling Cardiovascular Insights With Conditional Inference Trees

    Jun 1, 2024, 00:00

  • RWD23 Development of an Optimal Corticosteroid Dosage Regimen for the Management of Acute Respiratory Distress Syndrome: A Sequential Explanatory Mixed Method Approach

    Jun 1, 2024, 00:00

  • MT23 The Changing Healthcare Landscape of Lumbar Spinal Fusion: Two-Year Claims Database Analysis

    Jun 1, 2024, 00:00

  • CO61 Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Paroxysmal Supraventricular Tachycardia Episodes

    Jun 1, 2024, 00:00

  • EE241 JAV-RARAS: Microscopic Analysis of Patients with Familial Amyloidotic Polyneuropathy in Brazil

    Jun 1, 2024, 00:00

  • RWD70 Dental Complication Burden in Patients with Phosphorus Metabolism and Phosphatase Disorders: Insights from a 14-Year Nationwide Longitudinal Retrospective Study in South Korea

    Jun 1, 2024, 00:00

  • HSD45 Effectiveness of Aseptic and Disinfection Measures in Dental Offices in Barranquilla, Colombia

    Jun 1, 2024, 00:00

  • EPH78 Lung Cancer Screening Eligibility and Use in the US: A Cross-Sectional Analysis of 2022 Behavioral Risk Factor Surveillance System Data

    Jun 1, 2024, 00:00

  • CO17 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Immuno-Oncology (IO) for First-Line (1L) Esophageal Squamous Cell Carcinoma (ESCC) in Adult Patients

    Jun 1, 2024, 00:00

  • CO143 Clinical Outcomes of First-Line (1L) Treatments (Txs) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • CO147 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Entrectinib for Treatment of Metastatic Fusion-Positive Cancers in Children and Young Adults

    Jun 1, 2024, 00:00

  • PCR248 Comparison of Quality of Life Scales after Stroke in Hungarian and International Practice

    Jun 1, 2024, 00:00

  • MSR54 Estimating Drinking Trajectories in the United States From Adolescence to Old Age: A Three-Step Approach

    Jun 1, 2024, 00:00

  • RWD163 Medication Adherence and Persistence on Selumetinib Treatment in Pediatric Patients: A US Claims Database Analysis

    Jun 1, 2024, 00:00

  • PCR198 Assessing the Additional Value of Negative Multi-Cancer Early Detection (MCED) Tests: Results from an Online Survey of the General Population

    Jun 1, 2024, 00:00

  • MT26 HTA Requirements for Medical Technologies in Canada

    Jun 1, 2024, 00:00

  • CO211 Gout Epidemiology, Pharmacotherapy, Healthcare Utilization, and Outcomes for United States Veterans Affairs Patients From 2016 to 2022

    Jun 1, 2024, 00:00

  • PCR46 A Qualitative Exploration of Patient and Healthcare Provider Perspectives on Oxybate Treatments for Narcolepsy

    Jun 1, 2024, 00:00

  • Psychometric Properties of General Oral Health Assessment Index Across Ages: COSMIN Systematic Review

    Jun 1, 2024, 00:00

  • HSD92 Clinical Outcomes of Patients With Obesity in a US Employer-Funded Medical Weight Management Program: A Pilot Study

    Jun 1, 2024, 00:00

  • EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes New to Pump Therapy

    Jun 1, 2024, 00:00

  • EE72 Economic Burden of Long-Term Care (LTC) in Patients with Advanced Huntington's Disease (HD) and the Impact on Caregivers in North America: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE500 Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

    Jun 1, 2024, 00:00

  • RWD30 Ways To Minimize Data Quality Headaches in Migraine Research

    Jun 1, 2024, 00:00

  • CO184 A Matching-Adjusted Indirect Comparison of Centanafadine Vs Lisdexamfetamine, Methylphenidate, and Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: Long-Term Safety and Efficacy Outcomes

    Jun 1, 2024, 00:00

  • PCR147 Breaking a Vicious Cycle: Including the Patient Perspective for Meaningful Psoriasis Severity Evaluation Towards Broader Recognition of Burden and Unmet Needs

    Jun 1, 2024, 00:00

  • RWD114 Economic Burden, Treatment Utilization, and Medication Adherence of Post-Traumatic Stress Disorder (PTSD) Patients: A Retrospective Commercial and Medicare Part B Insurance Claims Analysis

    Jun 1, 2024, 00:00

  • RWD86 Impact of Population Aging on the Colombian Health System: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • PT34 Assessment of Direct, Indirect, and Intangible Costs of Rheumatoid Arthritis in Patients Receiving Biological Therapy in Morocco: Ecoram Study

    Jun 1, 2024, 00:00

  • PCR98 Suboptimal Dosing and Discontinuation of Antifibrotic Agents in Patients with Idiopathic Pulmonary Fibrosis (IPF)

    Jun 1, 2024, 00:00

  • EE503 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Healthcare Costs (HCC) of Patients with Small-Cell Lung Cancer (SCLC) in the US

    Jun 1, 2024, 00:00

  • P40 Caregivers’ Stated and Revealed Preferences for Antipsychotic Medication Use Among Youth: A Discrete Choice Experiment of Benefit-Risk Trade-Offs

    Jun 1, 2024, 00:00

  • EE442 Impact of Benralizumab on Asthma and COPD Exacerbation-Related Healthcare Resource Utilization in Patients with Asthma and Concomitant COPD

    Jun 1, 2024, 00:00

  • CO174 Baseline Characteristics of Patients with Asthma and Prior Oral Systemic Corticosteroid Use Initiating Dupilumab in a Real-World Registry (RAPID)

    Jun 1, 2024, 00:00

  • CO173 The Role of Mindfulness, Pelvic Floor Physical Therapy (PFPT), and Hypopressive Exercises for Chronic Pelvic Pain (CPP): Preliminary Results in Productivity Gain and Loss

    Jun 1, 2024, 00:00

  • HSD73 Neoadjuvant Adjuvant Therapy for Early-Stage/Resectable Non-Small Cell Lung Cancer (NSCLC): Physician Practices, Therapy Choice, and Challenges Among US Oncologists

    Jun 1, 2024, 00:00

  • EE28 Value of Knowing Risk of Developing Neurodegenerative Disease: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • EPH33 Trend of Mortality By Asthma in Colombia, 1998 - 2021

    Jun 1, 2024, 00:00

  • HSD118 Real-World Treatment Patterns and Cardiovascular Disease (CVD) Burden in Patients With Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Receiving Covalent Bruton’s Tyrosine Kinase Inhibitors (cBTKis)

    Jun 1, 2024, 00:00

  • EE426 Cost-Comparison Analysis of Non-Invasive Testing Strategies for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Veteran Population

    Jun 1, 2024, 00:00

  • RWD174 Health Care Resources Associated with Clinical Pneumonia, Bacteremia or Meningitis in Colombian Adults: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • EE466 Implementing the Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Sickle-Cell Disease: A Case Study

    Jun 1, 2024, 00:00

  • HTA19 A Targeted Review of NICE, CADTH and ICER Assessments: An Evaluation of the Joint Position Statement

    Jun 1, 2024, 00:00

  • EPH59 A Systematic Review on the Health Equity Disparities in Lupus Treatment: Medicaid Vs. Private Payer Outcomes

    Jun 1, 2024, 00:00

  • RWD172 Healthcare Utilization and Costs Among Patients With Episodic Migraine Initiating Galcanezumab Versus Rimegepant for Migraine Prevention in the United States

    Jun 1, 2024, 00:00

  • P64 Which Healthcare-System Factors Influence Reimbursement Success Rates? A Multi-Country Analysis of Reimbursement Decisions in 2023

    Jun 1, 2024, 00:00

  • HSD9 Oncology Practice Setting Classification in the US: Considerations for Real World Evidence

    Jun 1, 2024, 00:00

  • RWD151 Knowledge Management Tool: A Large Language Model-Based Search Engine

    Jun 1, 2024, 00:00

  • MSR102 Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis Comparing Binomial and Multinomial Approaches

    Jun 1, 2024, 00:00

  • HPR58 Mapping Medicaid: A Comparative Analysis of State-Level Racial and Ethnic Data Collection to Federal Guidelines

    Jun 1, 2024, 00:00

  • EPH70 Real-World Second-Line Treatment Pattern and Disease Burden of Patients With Unresectable or Advanced Hepatic Carcinoma in China: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • HSD60 Self-Reported Pain Severity and Opioid Utilization in Adult Patients with Spine-Related Problems

    Jun 1, 2024, 00:00

  • RWD38 The Use of Patient-Generated Functional Outcome Measures in Trials Seeking to Show Improvements in Negative Symptoms or Cognitive Impairment Associated with Schizophrenia

    Jun 1, 2024, 00:00

  • CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)

    Jun 1, 2024, 00:00

  • HPR50 How Do We Define Value in Health? Well, That Depends

    Jun 1, 2024, 00:00

  • MT44 Handheld Robotically Assisted Primary Unilateral Total Knee Arthroplasty (R-TKA) Demonstrates Lower Short-Term Costs and Length of Stay Compared to Conventional Instrumentation TKA (C-TKA)

    Jun 1, 2024, 00:00

  • MSR73 Lessons Learned from Confounder Identification: Insights from German HTA Procedures

    Jun 1, 2024, 00:00

  • RWD136 Regulatory Vs HTA Divergences- Can the Real-World Evidence (RWE) be the Connecting Bridge?

    Jun 1, 2024, 00:00

  • PCR70 Diagnostic Journey, Seizure Burden, and Quality of Life Among Patients With CDKL5 Deficiency Disorder Using Real-World Data

    Jun 1, 2024, 00:00

  • PCR103 Young People’s Preferences Towards Web-Based Mental Health Interventions for Anxiety and Depression: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • SA43 Potential for Drug Development Using Artificial Intelligence and Machine Learning

    Jun 1, 2024, 00:00

  • HTA82 Adjusting Utilities Using Age and Time-to-Death Decrements in Cost-Effectiveness Analyses: A Case Study in Relapsed and/or Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE385 Changes in Direct Costs of Breast Cancer in Colombia From 2011 to 2022

    Jun 1, 2024, 00:00

  • HTA27 An Analysis of Manufacturer and Patient Engagement with Institute for Clinical and Economic Review Assessments

    Jun 1, 2024, 00:00

  • EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments

    Jun 1, 2024, 00:00

  • CO67 Network Meta-Analysis to Compare the Efficacy Between Different Classes of PCSK9 Inhibitors, siRNA Vs. PCSK9 mAb, in Asian Patients With Hypercholesterolemia at Increased Cardiovascular Risk

    Jun 1, 2024, 00:00

  • MT39 Reporting Characteristics of Randomized Controlled Trials of Endovascular Therapy for Peripheral Artery Disease: A Systematic Review

    Jun 1, 2024, 00:00

  • HPR141 Model Analysis on Budget Impact and Patients’ Burden of National Price-Negotiated Drugs and Different Reimbursement Payment Modes in China: Hyperkalemia As an Example

    Jun 1, 2024, 00:00

  • RWD22 Utilizing Optum® Market Clarity Dataset for Analyzing Treatment Patterns and Clinical Outcomes in Diabetes: A Propensity Score Matched Study Comparing Gender Cohorts

    Jun 1, 2024, 00:00

  • EPH169 Integrating Structured and Unstructured Data in Total Hip Arthroplasty Evaluation: A Comprehensive Analysis for Enhanced Device Safety

    Jun 1, 2024, 00:00

  • RWD5 A Novel Predictive Model for Agitation in Alzheimer’s Dementia Using Administrative Claims Data

    Jun 1, 2024, 00:00

  • PCR199 Advancing Patient-Centered Outcomes Research for Rare Diseases: A Mixed-Methods Approach

    Jun 1, 2024, 00:00

  • PCR97 Consequences of Misdiagnosed Opsoclonus Myoclonus Ataxia Syndrome (OMAS)

    Jun 1, 2024, 00:00

  • EPH190 Trends and Disparities in Perinatal Health Outcomes Among Women from Refugee Backgrounds in Victoria, Australia: A Population-Based Study

    Jun 1, 2024, 00:00

  • HPR123 Impact of Mandated Use of the Texas Prescription Monitorsing Program on Carisoprodol Dispensing in Texas

    Jun 1, 2024, 00:00

  • CO180 Newer Glucose-Lowering Drugs and Risk of Depression: A Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • CO21 Association between Pregnant Cigarette Smoking and Offspring Birthweight Using Oracle EHR Real-World Data

    Jun 1, 2024, 00:00

  • P27 Uptake and Costs of Rituximab Biosimilars Among the Medicare and Medicaid Populations in 2019-2021 in the United States

    Jun 1, 2024, 00:00

  • EE301 Economic Burden of Disease Recurrence in Elderly Patients With High-Risk Endometrial Cancer (HR-EC) Receiving Adjuvant Therapy (AT)

    Jun 1, 2024, 00:00

  • CO172 Indirect Treatment Comparison of Efficacy and Safety of Capivasertib-Fulvestrant Versus Alpelisib-Fulvestrant for PIK3CA-Altered, HR-Positive, Advanced Breast Cancer after Disease Progression Following Endocrine-Based Therapy

    Jun 1, 2024, 00:00

  • CO24 Examination of the Effectiveness of a Shoulder Stabilization Programme Among Throwing Athletes

    Jun 1, 2024, 00:00

  • PCR119 Treatment Persistence Among Treatment-Experienced People With HIV (PWH) Switching To Integrase Strand Transfer Inhibitor (INSTI)-Based HIV Antiretroviral Regimens

    Jun 1, 2024, 00:00

  • PCR56 Are Limitations in Physical Function Relevant and Important Concepts To Assess in Patients on Antithrombotic Therapy for Cardiovascular Conditions?

    Jun 1, 2024, 00:00

  • PCR5 Perceptions, Experiences, and Behaviors of Patients and Their Caregivers With Gastric and Gastroesophageal Cancer Treated With or Without Trastuzumab Deruxtecan (T-DXd) in the United States

    Jun 1, 2024, 00:00

  • PT5 Impacts of National Drug Price Negotiation on Type 2 Diabetes Drugs Price, Volume, and Spending in China

    Jun 1, 2024, 00:00

  • EE179 Cost Effectiveness of Mastectomies of BRCA1 and BRCA2 Positive Women over Olaparib

    Jun 1, 2024, 00:00

  • EPH178 Representing Thyroid Cancer Epidemiology in the US Over Time: A Microsimulation Modeling Approach Incorporating Temporal Differences in Thyroid Ultrasound Utilization by Sex and Age

    Jun 1, 2024, 00:00

  • CO42 Disease Burden of Anal Carcinoma in Chinese Male Patients Under Current Care: A Model Simulation Study

    Jun 1, 2024, 00:00

  • PT26 Health Economic Impact of Non-Persistence with Tamoxifen Adjuvant Endocrine Therapy in Pre-Menopausal Women with Early-Stage Breast Cancer: A Simulation Study

    Jun 1, 2024, 00:00

  • EE39 Economic Evaluation of Botulinum Toxin Type A (XEOMEEN) in the Treatment of Pediatric Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • EE387 Healthcare Resource Utilization for Patients With Alzheimer's Disease Versus Non-Alzheimer's Disease Controls in Israel

    Jun 1, 2024, 00:00

  • HSD106 Metastatic Colorectal Cancer (mCRC) Patients Treated with Later Lines of Treatment (LOT): A Retrospective Analysis By Race and Ethnicity in the United States (US) Community Oncology Setting

    Jun 1, 2024, 00:00

  • EE334 The Diagnostic Odyssey and Cost-Effectiveness of Genomic Testing in Indigenous Children in British Columbia, Canada

    Jun 1, 2024, 00:00

  • EE493 Sociodemographic Factors of Asthma Prevalence and Costs for Children in the United States, 2016-2021

    Jun 1, 2024, 00:00

  • SA54 Expanding the Horizon of Cost-Effectiveness Analysis: A Comprehensive Review of Alternative Methods

    Jun 1, 2024, 00:00

  • PCR173 Health State Utilities Associated With X-Linked Retinitis Pigmentosa in the United States

    Jun 1, 2024, 00:00

  • RWD186 Economic Evaluation of Biosimilar Market in the US: Insights From a Real-World Analysis Using De-Identified Market Clarity Database

    Jun 1, 2024, 00:00

  • PCR175 Screening for Anxiety and Depressive Symptoms in Adolescents With Complex Health Conditions From a Longitudinal Registry Study in Los Angeles County: Comparative Performance of the EQ-5D-5L and PedsQL

    Jun 1, 2024, 00:00

  • EE505 Predictive Analysis Comparing Economic and Clinical Consequences of Treatment-related Hepatotoxicity in KRASG12C-mutated Advanced Non-small Cell Lung Cancer (aNSCLC) Patients Treated Post-immunotherapy (IO)

    Jun 1, 2024, 00:00

  • CO117 Factors Associated with Biologic Treatment De-Escalation in Patients with Crohn’s Disease

    Jun 1, 2024, 00:00

  • EE194 Health Care Resource Utilization, Total and out of Pocket Expenditures Among Adults with Rheumatoid Arthritis: Medical Expenditure Panel Survey Study

    Jun 1, 2024, 00:00

  • RWD58 Ketamine-Associated Adverse Events: An Analysis of the FAERS Database From 2012 - 2021

    Jun 1, 2024, 00:00

  • EE118 Impact of Different Thresholds on Recommendations Made Through Cost-Effectiveness Studies: An Example From Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • HSD44 Association of Penicillin Allergy Documentation and First-Line Penicillin Prescribing for Common Infections in Primary Healthcare Facilities in Beijing

    Jun 1, 2024, 00:00

  • CO121 Evaluating Disparities in Clinical Outcomes Among Medicare Beneficiaries With Peripheral Artery Disease (PAD): A Call To Action for Health Equity

    Jun 1, 2024, 00:00

  • Economic Evaluation

    Jun 1, 2024, 00:00

  • HSD84 Prescription Contraceptive Use Among Medicaid-Insured Women With Obesity in the United States

    Jun 1, 2024, 00:00

  • EE261 Costs and Outcomes Associated with COVID-19 Hospitalisation in the South African Public-Sector during the First-Wave

    Jun 1, 2024, 00:00

  • MT32 Novel Graft Materials for Lumbar Spinal Fusion Procedures:12 Months Outcomes

    Jun 1, 2024, 00:00

  • EE403 Budget Impact of Selinexor Combination Regimens in Previously Treated Multiple Myeloma

    Jun 1, 2024, 00:00

  • PCR200 Content Validity of FACT-GP5 to Assess Treatment Tolerability in Participants With Progressive, Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer: Qualitative Interview Sub-Study of the LIBRETTO-531 Trial

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • MSR29 Application of a Novel Bayesian Dynamic Borrowing Approach Using Anonymized Finnish Real-World Data As an External Control Arm to Augment an Internal Control Arm of a Randomized Clinical Trial

    Jun 1, 2024, 00:00

  • HPR36 Barriers to Getting New Cancer Medicines to Patients in Kazakhstan

    Jun 1, 2024, 00:00

  • EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia

    Jun 1, 2024, 00:00

  • CO190 Lumbar Spine Problems Caused By Hyperextension and It's Prevention, As Well As Balance Development in Rhythmic Gymnasts

    Jun 1, 2024, 00:00

  • EPH45 Survey of Residents’ Perceptions and Concerns on Air Pollution in Maharashtra, India

    Jun 1, 2024, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »